FDA Peptide Reclassification 2026 Amanecia Health Revance and TEOXANE Labs Get FDA Approval for RHA Dynamic Volume Revance posted on the topic LinkedIn FDA Approves Oral Semaglutide as the First Oral GLP 1 Pill Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin